HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Liver Cancer

Liver Cancer

Liver cancer, especially hepatocellular carcinoma (HCC), poses a significant health challenge worldwide. Recent strides in cancer research are revolutionizing its diagnosis and treatment. Advances in genomic profiling are uncovering critical molecular mechanisms, paving the way for tailored therapies. Immunotherapy, particularly with immune checkpoint inhibitors, is showing encouraging results by boosting the body's immune response against cancer cells. Additionally, innovative imaging techniques are enhancing the early detection and monitoring of liver tumors. Researchers are also investigating combination therapies that merge traditional methods like surgery and chemotherapy with new treatments to achieve better outcomes. Ongoing research is vital to fully understand liver cancer and develop more effective, targeted therapies.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp